Stupfler B, Verriez C, Gallois-Montbrun S, Marquet R, Paillart J
Viruses. 2021; 13(4).
PMID: 33916704
PMC: 8066197.
DOI: 10.3390/v13040617.
Li G, De Clercq E
Microbiol Mol Biol Rev. 2016; 80(3):679-731.
PMID: 27357278
PMC: 4981665.
DOI: 10.1128/MMBR.00065-15.
Racine P, Chamontin C, de Rocquigny H, Bernacchi S, Paillart J, Mougel M
Sci Rep. 2016; 6:27536.
PMID: 27273064
PMC: 4895152.
DOI: 10.1038/srep27536.
Sleiman D, Bernacchi S, Xavier Guerrero S, Brachet F, Larue V, Paillart J
RNA Biol. 2014; 11(7):906-20.
PMID: 25144404
PMC: 4179964.
DOI: 10.4161/rna.29546.
Costa K, Leal E, Dos Santos A, E Lima A, Alves C, Lameira J
PLoS One. 2014; 9(2):e89116.
PMID: 24586532
PMC: 3935857.
DOI: 10.1371/journal.pone.0089116.
APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.
Batisse J, Xavier Guerrero S, Bernacchi S, Richert L, Godet J, Goldschmidt V
J Virol. 2013; 87(11):6492-506.
PMID: 23576497
PMC: 3648125.
DOI: 10.1128/JVI.03494-12.
Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides.
Reingewertz T, Britan-Rosich E, Rotem-Bamberger S, Viard M, Jacobs A, Miller A
Bioorg Med Chem. 2013; 21(12):3523-32.
PMID: 23545135
PMC: 7039049.
DOI: 10.1016/j.bmc.2013.03.001.
Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
Zhou X, Evans S, Han X, Liu Y, Yu X
PLoS One. 2012; 7(3):e33495.
PMID: 22479405
PMC: 3316577.
DOI: 10.1371/journal.pone.0033495.
Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.
Xue B, Mizianty M, Kurgan L, Uversky V
Cell Mol Life Sci. 2011; 69(8):1211-59.
PMID: 22033837
PMC: 11114566.
DOI: 10.1007/s00018-011-0859-3.
Initiation of HIV Reverse Transcription.
Isel C, Ehresmann C, Marquet R
Viruses. 2011; 2(1):213-243.
PMID: 21994608
PMC: 3185550.
DOI: 10.3390/v2010213.
Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif.
Bernacchi S, Mercenne G, Tournaire C, Marquet R, Paillart J
Nucleic Acids Res. 2010; 39(6):2404-15.
PMID: 21076154
PMC: 3064812.
DOI: 10.1093/nar/gkq979.
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
Hultquist J, Harris R
Future Virol. 2010; 4(6):605.
PMID: 20174454
PMC: 2822356.
DOI: 10.2217/fvl.09.59.
RNA interference targeted to the conserved dimerization initiation site (DIS) of HIV-1 restricts virus escape mutation.
Sugiyama R, Habu Y, Ohnari A, Miyano-Kurosaki N, Takaku H
J Biochem. 2009; 146(4):481-9.
PMID: 19556221
PMC: 7539327.
DOI: 10.1093/jb/mvp093.
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Henriet S, Mercenne G, Bernacchi S, Paillart J, Marquet R
Microbiol Mol Biol Rev. 2009; 73(2):211-32.
PMID: 19487726
PMC: 2698415.
DOI: 10.1128/MMBR.00040-08.
Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase.
Kataropoulou A, Bovolenta C, Belfiore A, Trabatti S, Garbelli A, Porcellini S
Nucleic Acids Res. 2009; 37(11):3660-9.
PMID: 19369217
PMC: 2699511.
DOI: 10.1093/nar/gkp226.
The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.
DaFonseca S, Coric P, Gay B, Hong S, Bouaziz S, Boulanger P
Virol J. 2008; 5:162.
PMID: 19105849
PMC: 2628355.
DOI: 10.1186/1743-422X-5-162.
Human T-cell lymphotropic virus type 1 nucleocapsid protein-induced structural changes in transactivation response DNA hairpin measured by single-molecule fluorescence resonance energy transfer.
Darugar Q, Kim H, Gorelick R, Landes C
J Virol. 2008; 82(24):12164-71.
PMID: 18829758
PMC: 2593354.
DOI: 10.1128/JVI.01158-08.
Advances in the structural understanding of Vif proteins.
Barraud P, Paillart J, Marquet R, Tisne C
Curr HIV Res. 2008; 6(2):91-9.
PMID: 18336256
PMC: 2704546.
DOI: 10.2174/157016208783885056.
Nucleocapsid mutations turn HIV-1 into a DNA-containing virus.
Houzet L, Morichaud Z, Didierlaurent L, Muriaux D, Darlix J, Mougel M
Nucleic Acids Res. 2008; 36(7):2311-9.
PMID: 18296486
PMC: 2367716.
DOI: 10.1093/nar/gkn069.
The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
Miller J, Presnyak V, Smith H
Retrovirology. 2007; 4:81.
PMID: 18036235
PMC: 2222665.
DOI: 10.1186/1742-4690-4-81.